Table 2.
Clinicopathological analysis of ICAM-1 mRNA and HCC % (n)
| Clinical data | Cases | Positive tumor | Positive paratumor |
| ICAM-1 mRNA | ICAM-1 mRNA | ||
| Serum AFP > 400 μg/L | 25 | 68.0 (17/25) | 32.0 (8/25) |
| Serum AFP < 400 μg/L | 18 | 61.1 (11/18) | 27.8 (5/18) |
| sICAM-1 > 1000 μg/La | 32 | 75.0 (25/32) | 34.4 (11/32) |
| < 1000 μg/L | 11 | 36.4 (3/11) | 18.2 (2/11) |
| Severe cirrhosisa Yes | 30 | 80.0 (24/30) | 36.7 (11/30) |
| No | 13 | 30.8 (4/13) | 15.4 (2/13) |
| Differentiation High | 15 | 66.7 (10/15) | 33.3 (4/15) |
| Low | 28 | 64.3 (18/28) | 32.1 (9/28) |
| Tumor size > 5 cm | 31 | 66.7 (8/12) | 25.0 (3/12) |
| < 5 cm | 12 | 64.5 (20/31) | 32.3 (10/31) |
| Intrahepatic metastasisb Yes | 15 | 86.7 (13/15) | 40.0 (6/15) |
| No | 28 | 46.4 (13/28) | 25.0 (7/28) |
a
P < 0.01;
b
P < 0.05